# Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients

> **NCT01011699** · PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 176 (actual)

## Conditions studied

- Chronic Renal Failure
- Hemodialysis

## Interventions

- **DRUG:** nicotinamide
- **DRUG:** sevelamer
- **DRUG:** cinacalcet

## Key facts

- **NCT ID:** NCT01011699
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 176 (ACTUAL)
- **Why stopped:** Financial problem
- **Last updated:** 2016-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01011699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01011699, "Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01011699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*